InMed Pharmaceuticals, Inc. (NASDAQ: INM)

Name: InMed Pharmaceuticals, Inc. (NASDAQ: INM)
Uploaded: 2024-06-13T10:36:56-07:00
Duration: 1596 s
Description: InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors.Keynote speaker: Eric Adams, CEO